FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Kronox Lab Sciences IPO and Stanley Lifestyles IPO.
Kronox Lab Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Stanley Lifestyles IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Pantomath Capital Advisors Pvt Ltd | Axis Capital Limited ICICI Securities Limited Jm Financial Limited SBI Capital Markets Limited |
Registrar | Kfin Technologies Limited | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Kronox Lab Sciences IPO is up to ₹130.15 Cr whereas the issue size of the Stanley Lifestyles IPO is up to ₹537.02 Cr. The final issue price of Kronox Lab Sciences IPO is ₹136.00 per share and of Stanley Lifestyles IPO is ₹369.00 per share.
Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |
---|---|---|
Face Value | ₹10 per share | ₹2 per share |
Issue Price (Lower) | ₹129.00 per share | ₹351.00 per share |
Issue Price (Upper) | ₹136.00 per share | ₹369.00 per share |
Issue Price (Final) | ₹136.00 per share | ₹369.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 110 shares | 40 shares |
Fresh Issue Size | 54,20,054 shares | |
Fresh Issue Size (Amount) | up to ₹200.00 Cr | |
OFS Issue Size | 95,70,000 shares | 91,33,454 shares |
OFS Issue Size (Amount) | up to ₹130.15 Cr | up to ₹337.02 Cr |
Issue Size Total | 95,70,000 shares | 1,45,53,508 shares |
Issue Size Total (Amount) | up to ₹130.15 Cr | up to ₹537.02 Cr |
Kronox Lab Sciences IPO opens on Jun 03, 2024, while Stanley Lifestyles IPO opens on Jun 21, 2024. The closing date of Kronox Lab Sciences IPO and Stanley Lifestyles IPO is Jun 05, 2024, and Jun 25, 2024, respectively.
Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |
---|---|---|
Anchor Bid Date | May 31, 2024 | Jun 20, 2024 |
Issue Open | Jun 03, 2024 | Jun 21, 2024 |
Issue Close | Jun 05, 2024 | Jun 25, 2024 |
Basis Of Allotment (Tentative) | Jun 06, 2024 | Jun 26, 2024 |
Initiation of Refunds (Tentative) | Jun 07, 2024 | Jun 27, 2024 |
Credit of Share (Tentative) | Jun 07, 2024 | Jun 27, 2024 |
Listing date (Tentative) | Jun 10, 2024 | Jun 28, 2024 |
Anchor Lockin End date 1 | Jul 06, 2024 | Jul 26, 2024 |
Anchor Lockin End date 2 | Sep 04, 2024 | Sep 24, 2024 |
Kronox Lab Sciences IPO P/E ratio is 30.37, as compared to Stanley Lifestyles IPO P/E ratio of 54.43.
Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Kronox Lab Sciences Limited Financial Information (Restated)Kronox Lab Sciences Limited's revenue increased by 16.99% and profit after tax (PAT) rose by 21.94% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Stanley Lifestyles Limited Financial Information (Restated Consolidated)Stanley Lifestyles Limited's revenue increased by 42.94% and profit after tax (PAT) rose by 50.64% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.98% | 67.36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 74.21% | 56.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 30.37 | 54.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹504.61 Cr. | ₹2103.94 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 25.66%% | 7.92%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 33.15%% | 8.63%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹4.48 | ₹6.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 25.66%% | 8.34%% |
In the Kronox Lab Sciences IPO retail investors (RII) are offered 33,49,500 shares while in Stanley Lifestyles IPO retail investors are offered 33,49,500 shares. Qualified institutional buyers (QIB) are offered 19,14,000 shares in Kronox Lab Sciences IPO and 29,10,702 shares in Stanley Lifestyles IPO.
Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |
---|---|---|
Anchor Investor Reserveration | 28,71,000 shares | 43,66,051 shares |
Market Maker Reserveration | ||
QIB | 19,14,000 shares | 29,10,702 shares |
NII | 14,35,500 shares | 21,83,026 shares |
RII | 33,49,500 shares | 50,93,728 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 66,99,000 shares | 1,01,87,456 shares |
Kronox Lab Sciences IPO subscribed 117.25x in total, whereas Stanley Lifestyles IPO subscribed 97.16x.
Kronox Lab Sciences IPO | Stanley Lifestyles IPO | |
---|---|---|
QIB (times) | 89.03x | 215.62x |
NII (times) | 301.92x | 121.42x |
Big NII (times) | 322.26x | 136.75x |
Small NII (times) | 261.22x | 90.76x |
RII (times) | 54.24x | 19.08x |
Employee (times) | ||
Other (times) | ||
Total (times) | 117.25x | 97.16x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|